Business Description
SANUWAVE Health Inc
NAICS : 325414
SIC : 2836
ISIN : US80303D3052
Total Employee Number:
55Description
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.49 | |||||
Equity-to-Asset | 0.05 | |||||
Debt-to-Equity | 12.06 | |||||
Debt-to-EBITDA | 0.98 | |||||
Interest Coverage | 0.57 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -4.89 | |||||
Beneish M-Score | -2.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -24.9 | |||||
3-Year EBITDA Growth Rate | -13.2 | |||||
3-Year EPS without NRI Growth Rate | 70.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 24.06 | |||||
9-Day RSI | 31.05 | |||||
14-Day RSI | 33.5 | |||||
3-1 Month Momentum % | -19.7 | |||||
6-1 Month Momentum % | -47.14 | |||||
12-1 Month Momentum % | -55.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.31 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.59 | |||||
Days Inventory | 212.51 | |||||
Days Sales Outstanding | 39.12 | |||||
Days Payable | 132.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -80.4 | |||||
Shareholder Yield % | 8.33 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.74 | |||||
Operating Margin % | 6.4 | |||||
Net Margin % | 36.21 | |||||
EBITDA Margin % | 50.89 | |||||
FCF Margin % | 8.69 | |||||
OCF Margin % | 13.06 | |||||
ROE % | Neg. Equity | |||||
ROA % | 46.14 | |||||
ROIC % | 8.23 | |||||
3-Year ROIIC % | -34.5 | |||||
ROC (Joel Greenblatt) % | 842.03 | |||||
ROCE % | 431.13 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 20.27 | |||||
Forward PE Ratio | 7.8 | |||||
Price-to-Owner-Earnings | 4 | |||||
PS Ratio | 1.33 | |||||
PB Ratio | 31.86 | |||||
Price-to-Free-Cash-Flow | 15.32 | |||||
Price-to-Operating-Cash-Flow | 10.31 | |||||
EV-to-EBIT | 3.27 | |||||
EV-to-EBITDA | 3.05 | |||||
EV-to-Forward-EBITDA | 13.62 | |||||
EV-to-Revenue | 1.55 | |||||
EV-to-Forward-Revenue | 2.83 | |||||
EV-to-FCF | 17.89 | |||||
Price-to-GF-Value | 0.56 | |||||
Price-to-Median-PS-Value | 0.17 | |||||
Earnings Yield (Greenblatt) % | 30.58 | |||||
FCF Yield % | 6.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SNWV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SANUWAVE Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 44.328 | ||
| EPS (TTM) ($) | 0.33 | ||
| Beta | 0.4642 | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 0.82 | ||
| Volatility % | 59.73 | ||
| 14-Day RSI | 33.5 | ||
| 14-Day ATR ($) | 1.469346 | ||
| 20-Day SMA ($) | 9.781 | ||
| 12-1 Month Momentum % | -55.91 | ||
| 52-Week Range ($) | 6.111 - 46.585 | ||
| Shares Outstanding (Mil) | 8.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SANUWAVE Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SANUWAVE Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:30 | In 114 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 113 days | ||
| General meeting for 2025 | 2026-08-19 10:00 | In 35 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:30 | In 23 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 22 days | ||
| First quarter earnings conference call for 2026 | 2026-05-13 08:30 | 16.04 (+0.12%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 16.00 (+1.01%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-27 08:30 | 18.85 (-4.41%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-27 | 18.85 (-4.41%) | ||
| Annual report for 2025 | 2026-03-26 | 19.93 (-2.30%) |
Show
Entries
SANUWAVE Health Inc Frequently Asked Questions
What is SANUWAVE Health Inc(SNWV)'s stock price today?
The current price of SNWV is $6.69. The 52 week high of SNWV is $46.59 and 52 week low is $6.11.
When is next earnings date of SANUWAVE Health Inc(SNWV)?
The next earnings date of SANUWAVE Health Inc(SNWV) is 2026-08-07 Est..
Does SANUWAVE Health Inc(SNWV) pay dividends? If so, how much?
SANUWAVE Health Inc(SNWV) does not pay dividend.
Guru Commentaries on NAS:SNWV
No articles.

